GSK reports positive pivotal phase III data for next-generation low carbon version of Ventolin metered dose inhaler: London, UK Thursday, October 23, 2025, 11:00 Hrs [IST] GSK plc ...
For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...
The nursing team at Court Street Medical Practice in Madeley is heading to The Grosvenor Hotel in London tomorrow (October 23 ...
In the first randomised controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be ...
In the first randomised controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5–15, an international team found the combined treatment to be more ...
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomized controlled trial to investigate the use of a ...
A combination reliever inhaler containing an inhaled corticosteroid significantly reduces asthma attacks compared with salbutamol alone in children, a large international trial has reported. It is the ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ASMOL INHALER contains the active ingredient salbutamol sulfate. ASMOL ...
The respiratory medical community is moving toward shared decision-making in self-managing chronic respiratory disease, but ...
A new study found that a 2-in-1 anti-inflammatory inhaler reduced asthma attacks in children by 45% compared to the widely-used salbutamol inhaler. The corresponding study was published in The Lancet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results